These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 21819342)
21. Utility of the triple test in the detection of abnormalities of the feto-placental unit. Perenc M; Dudarewicz L; Kałuzewski B Med Sci Monit; 2000; 6(5):994-9. PubMed ID: 11208444 [TBL] [Abstract][Full Text] [Related]
22. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome. Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624 [TBL] [Abstract][Full Text] [Related]
23. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS). Craig WY; Haddow JE; Palomaki GE; Roberson M Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308 [TBL] [Abstract][Full Text] [Related]
24. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population. Xie Z; Lu S; Li H Prenat Diagn; 2010 Jan; 30(1):74-6. PubMed ID: 19967750 [TBL] [Abstract][Full Text] [Related]
25. Serologic assay of Helicobacter pylori infection. Is it useful in hyperemesis gravidarum? Berker B; Soylemez F; Cengiz SD; Kose SK J Reprod Med; 2003 Oct; 48(10):809-12. PubMed ID: 14619649 [TBL] [Abstract][Full Text] [Related]
26. Relation between plasma adenosine and serum TSH levels in women with hyperemesis gravidarum. Murata T; Suzuki S; Takeuchi T; Takeshita T Arch Gynecol Obstet; 2006 Mar; 273(6):331-6. PubMed ID: 16292579 [TBL] [Abstract][Full Text] [Related]
28. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly. Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663 [TBL] [Abstract][Full Text] [Related]
29. The incidence of hyperemesis gravidarum is increased among Pacific Islanders living in Wellington. Jordan V; MacDonald J; Crichton S; Stone P; Ford H N Z Med J; 1995 Aug; 108(1006):342-4. PubMed ID: 7566763 [TBL] [Abstract][Full Text] [Related]
30. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected? Christiaens GC; Hagenaars AM; Akkerman C; De France HF Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002 [TBL] [Abstract][Full Text] [Related]
32. [Prenatal screening for major fetal defects by using of maternal serum markers]. Bao P; Wu Y; Gu Q Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):649-51. PubMed ID: 9639762 [TBL] [Abstract][Full Text] [Related]
33. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ; Watt HC Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278 [TBL] [Abstract][Full Text] [Related]
34. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol. Hogge WA; Fraer L; Melegari T Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881 [TBL] [Abstract][Full Text] [Related]
35. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. Goodwin TM; Montoro M; Mestman JH; Pekary AE; Hershman JM J Clin Endocrinol Metab; 1992 Nov; 75(5):1333-7. PubMed ID: 1430095 [TBL] [Abstract][Full Text] [Related]
36. Adjusted leptin level (ALL) is a predictor for hyperemesis gravidarum. Demir B; Erel CT; Haberal A; Oztürk N; Güler D; Koçak M Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):193-6. PubMed ID: 16051421 [TBL] [Abstract][Full Text] [Related]
37. Increased concentration of the free beta-subunit of human chorionic gonadotropin in hyperemesis gravidarum. Goodwin TM; Hershman JM; Cole L Acta Obstet Gynecol Scand; 1994 Nov; 73(10):770-2. PubMed ID: 7817726 [TBL] [Abstract][Full Text] [Related]
38. Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes. Chitayat D; Farrell SA; Huang T; Meier C; Wyatt PR; Summers AM Am J Obstet Gynecol; 2002 Sep; 187(3):758-63. PubMed ID: 12237660 [TBL] [Abstract][Full Text] [Related]
39. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
40. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases]. Arbuzova SB; Nikolenko MI Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]